Pacer Advisors Inc. Acquires 541,468 Shares of Cencora, Inc. $COR

Pacer Advisors Inc. lifted its stake in shares of Cencora, Inc. (NYSE:COR) by 2,682.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 561,655 shares of the company’s stock after buying an additional 541,468 shares during the quarter. Pacer Advisors Inc. owned about 0.29% of Cencora worth $189,699,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in COR. AustralianSuper Pty Ltd acquired a new stake in shares of Cencora during the third quarter worth $26,191,000. Lansforsakringar Fondforvaltning AB publ grew its stake in Cencora by 5.4% during the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 60,254 shares of the company’s stock worth $18,831,000 after buying an additional 3,073 shares in the last quarter. Chilton Investment Co. Inc. bought a new position in Cencora in the 3rd quarter valued at about $459,000. Nordea Investment Management AB increased its stake in Cencora by 3.8% in the fourth quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock valued at $426,715,000 after acquiring an additional 45,712 shares during the last quarter. Finally, Groupama Asset Managment acquired a new position in shares of Cencora during the 3rd quarter worth $1,225,000. 97.52% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. UBS Group upped their price objective on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Morgan Stanley set a $342.00 price objective on Cencora in a research report on Friday, May 8th. William Blair initiated coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Evercore set a $360.00 price target on Cencora in a research note on Wednesday, April 8th. Finally, Citigroup cut their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Cencora has an average rating of “Moderate Buy” and a consensus price target of $374.00.

Cencora Price Performance

COR opened at $271.99 on Friday. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The company has a market capitalization of $52.92 billion, a price-to-earnings ratio of 20.86, a P/E/G ratio of 1.50 and a beta of 0.59. The firm’s fifty day moving average price is $285.65 and its two-hundred day moving average price is $324.72. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The firm had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the previous year, the company posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, analysts anticipate that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora declared that its board has authorized a stock repurchase program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to reacquire up to 3.9% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its shares are undervalued.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.9%. Cencora’s dividend payout ratio is presently 18.40%.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.